advertisement

WGW-2021

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (62)

Showing records 1 to 25

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Kumar S
Romanian journal of ophthalmology 2019; 63: 249-256
82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Franca JR
International Journal of Pharmaceutics 2019; 570: 118662
82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Ha JY
Chonnam medical journal 2019; 55: 156-162
82174 The Impact of R-801 Nanoparticles as a Long Acting Topical Glaucoma Therapy
Ibrahim MM
Journal of biomedical nanotechnology 2019; 15: 1968-1981
82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Yadav M
Data in brief 2019; 25: 104361
82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Juliana FR
Molecules 2019; 24:
82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Mittal N
International Journal of Biological Macromolecules 2019; 139: 1252-1262
82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 781-792
82710 Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review
Cegielska O
Polymers 2019; 11:
82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Lee SM
Indian Journal of Ophthalmology 2019; 67: 1297-1302
82430 Latanoprost uptake and release from commercial contact lenses
Horne RR
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19
82599 Applications of microneedles in delivering drugs for various ocular diseases
Gupta P
Life Sciences 2019; 237: 116907
82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Taskar PS
Translational vision science & technology 2019; 8: 15
82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Duru Z
Cutaneous and Ocular Toxicology 2020; 39: 21-24
82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Murugesan V
British Journal of Ophthalmology 2019; 0:
82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Patil A
Translational vision science & technology 2019; 8: 15
82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Altamimi ASA
Expert Opinion on Therapeutic Patents 2019; 29: 781-792
82430 Latanoprost uptake and release from commercial contact lenses
Rich JT
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19
82174 The Impact of R-801 Nanoparticles as a Long Acting Topical Glaucoma Therapy
Jablonski MM
Journal of biomedical nanotechnology 2019; 15: 1968-1981
82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Guzman-Aranguez A
Data in brief 2019; 25: 104361
82599 Applications of microneedles in delivering drugs for various ocular diseases
Yadav KS
Life Sciences 2019; 237: 116907
82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Kesse S
Molecules 2019; 24:
82710 Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review
Sajkiewicz P
Polymers 2019; 11:
82599 Applications of microneedles in delivering drugs for various ocular diseases
Yadav KS
Life Sciences 2019; 237: 116907
82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Foureaux G
International Journal of Pharmaceutics 2019; 570: 118662

Issue 20-4

Select Issue


advertisement

WGC-2021